[Effect of glucocorticoids, tocolytics and oxytocin on the status and fate of premature infants].
Szczurowicz
A
A
Witczak
A
A
Rumistrzewicz
E
E
D003907:Dexamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000139:chemically induced*; D007567:Jaundice, Neonatal / Q000139:chemically induced*; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn / Q000139:chemically induced; D015149:Tocolytic Agents / Q000008:administration & dosage*
D015149:Tocolytic Agents; C004180:dexamethasone 21-phosphate; D010121:Oxytocin; D003907:Dexamethasone
Wpływ glikokortykosterydów, tokolityków i oksytocyny na stan i losy noworodków z porodów przedwczesnych.